- Home
- PRPO
PRPO
Precipio Inc.
as 07-15-2025 3:37pm EST
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents, and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | OMAHA |
| Market Cap: | 17.1M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 17.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.08 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.90 - $16.89 | Next Earning Date: | 08-12-2025 |
| Revenue: | $20,029,000 | Revenue Growth: | 26.67% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Precipio Inc. (PRPO)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| SANDBERG RICHARD A | PRPO | Director | May 30 '25 | Buy | $9.72 | 1,399 | $13,985.52 | 40,175 | |
| SANDBERG RICHARD A | PRPO | Director | May 27 '25 | Buy | $9.80 | 101 | $989.80 | 40,175 | |
| SANDBERG RICHARD A | PRPO | Director | May 22 '25 | Buy | $9.33 | 500 | $4,665.00 | 40,175 | |
| SANDBERG RICHARD A | PRPO | Director | May 21 '25 | Buy | $9.28 | 8,035 | $74,473.75 | 40,175 | |
| SANDBERG RICHARD A | PRPO | Director | May 19 '25 | Buy | $8.34 | 9,930 | $83,735.82 | 40,175 |
Latest Precipio Inc. News
PRPO Breaking Stock News: Dive into PRPO Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Precipio is requesting Shareholders/Brokers vote today to avoid costly adjournment and rescheduling of Annual Shareholders Meeting
GuruFocus.com
2 months ago
Precipio Inc (PRPO) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Operational ...
GlobeNewswire
2 months ago
Precipio Announces its Q1-2025 Financial Results
GlobeNewswire
2 months ago
Precipio Announces Q1-2025 Shareholder Update Call
Zacks
3 months ago
The Zacks Analyst Blog Highlights Visa, ServiceNow, The Progressive, The Monarch Cement and Precipio
Zacks
3 months ago
Top Research Reports for Visa, ServiceNow & Progressive
GuruFocus.com
3 months ago
Precipio Inc (PRPO) Q4 2024 Earnings Call Highlights: Break-Even Achieved and Strategic Growth ...
Simply Wall St.
4 months ago
Precipio Full Year 2024 Earnings: US$2.93 loss per share (vs US$4.51 loss in FY 2023)
Compare PRPO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "PRPO Precipio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.